glycyrrhetinic acid has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alami, M; Brion, JD; Le Bras, G; Marsaud, V; Peyrat, JF; Radanyi, C; Renoir, JM; Stella, B | 1 |
| Alper, P; Ari, F; Salakhutdinov, NF; Salomatina, OV; Ulukaya, E | 1 |
2 other study(ies) available for glycyrrhetinic acid and Breast Neoplasms
| Article | Year |
|---|---|
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Drug Screening Assays, Antitumor; Estradiol; Estrogen Receptor alpha; Female; Flow Cytometry; HSP90 Heat-Shock Proteins; Humans; Novobiocin; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-raf; Receptor, ErbB-2; Signal Transduction; Structure-Activity Relationship; Transcription, Genetic | 2007 |
Soloxolone methyl, as a 18βH-glycyrrhetinic acid derivate, may result in endoplasmic reticulum stress to induce apoptosis in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Female; Humans; Molecular Conformation; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |